No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs546557721 |
chr7:5486029-5486030 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs62440960 |
chr7:5486032-5486033 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs4724684 |
chr7:5486041-5486042 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs117418571 |
chr7:5486051-5486052 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs569424694 |
chr7:5486058-5486059 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs4236391 |
chr7:5486082-5486083 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs567223553 |
chr7:5486124-5486125 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs534715159 |
chr7:5486163-5486164 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs184227541 |
chr7:5486192-5486193 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs577759009 |
chr7:5486218-5486219 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs147259264 |
chr7:5486220-5486221 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs557006592 |
chr7:5486241-5486242 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs142683673 |
chr7:5486297-5486298 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs539452618 |
chr7:5486302-5486303 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs140826441 |
chr7:5486339-5486340 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs542427560 |
chr7:5486355-5486356 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs13223393 |
chr7:5486356-5486357 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
18 |
rs528526422 |
chr7:5486397-5486398 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs540334931 |
chr7:5486398-5486399 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs564936522 |
chr7:5486536-5486537 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs11767907 |
chr7:5486617-5486618 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
22 |
rs551241532 |
chr7:5486662-5486663 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs569478949 |
chr7:5486711-5486712 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs369142801 |
chr7:5486741-5486742 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs530447153 |
chr7:5486816-5486817 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs144371951 |
chr7:5486841-5486842 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs11982854 |
chr7:5486863-5486864 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs116659942 |
chr7:5486896-5486897 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs11982148 |
chr7:5486900-5486901 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs372762192 |
chr7:5486916-5486917 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs374559320 |
chr7:5486934-5486935 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs11978624 |
chr7:5486964-5486965 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs538284044 |
chr7:5486969-5486970 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs558791059 |
chr7:5486991-5486992 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs368738867 |
chr7:5487002-5487003 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs11971685 |
chr7:5487028-5487029 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs575413501 |
chr7:5487072-5487073 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs73059768 |
chr7:5487109-5487110 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs554422549 |
chr7:5487122-5487123 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs575516070 |
chr7:5487156-5487157 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs74603345 |
chr7:5487159-5487160 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs112158858 |
chr7:5487160-5487161 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs201456561 |
chr7:5487161-5487162 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs374697096 |
chr7:5487163-5487164 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs113725686 |
chr7:5487164-5487165 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs572748749 |
chr7:5487167-5487168 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs112293214 |
chr7:5487168-5487169 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs192230616 |
chr7:5487179-5487180 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs546486182 |
chr7:5487189-5487190 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs565075475 |
chr7:5487190-5487191 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|